|
GB0601950D0
|
|
Compositions and methods of treating diabetes
|
|
GB0511269D0
|
|
Sustained release preparation of pro-insulin C-peptide
|
|
GB0412174D0
|
|
Degradation-resistant analogues of pro-insulin c-peptide
|
|
GB0323979D0
|
|
Therapeutic applications for c-peptide
|
|
GB0218970D0
|
|
Fragments of Insulin c-peptide
|
|
EP1337243A2
|
|
Delayed-release pharmaceutical formulations containing proinsulin c-peptide
|
|
GB0022342D0
|
|
Reduction of the electrocardiographic QT interval
|
|
CZ2000444A3
|
|
Process for preparing insulin C-peptide
|
|
CZ108599A3
|
|
Peptide being fragment of human insulin c-peptide
|
|
GB9716790D0
|
|
Recombinant DNA molecules comprising multimeric copies of a gene sequence and expression thereof
|
